| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000237021.2 |
GSK1904529A |
Bladder urothelial carcinoma |
0.030273574 |
Resistant |
| ENSG00000237021.2 |
GSK1904529A |
Lung squamous cell carcinoma |
0.010573978 |
Resistant |
| ENSG00000237021.2 |
GSK1904529A |
Colon adenocarcinoma |
0.049376817 |
Sensitive |
